Fauci says Pfizer coronavirus vaccine likely available for high-risk cases by December
Dr. Anthony Fauci, the U.S. government's top infectious disease expert, said that a coronavirus vaccine could be available for the nation's highest-risk individuals as soon as December.
Pfizer says early data signals COVID-19 vaccine is 90% effective
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.
COVID-19 vaccine: Who will get the first doses?
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
Study suggests antibody immunity to COVID-19 could wane over time
A new study of hundreds of thousands of people across England suggests that antibody immunity following COVID-19 infection could wane over time.
Federal health officials planning to get coronavirus shots to nursing homes
The nation has 15,000-16,000 nursing homes, according to the Centers for Disease Control and Prevention. There may be another 20,000-45,000 assisted living facilities and similar kinds of settings for elderly and disabled people.
Remdesivir among 4 drugs with 'little or no effect' on COVID-19 survival, WHO study says
The WHO study looked at four existing COVID-19 treatments, including remdesivir and hydroxychloroquine, and found each had "little or no effect" on a patient's survival.